We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Editorial JCM 142
Did you know?
For the cost of 5 articles (students) or 10 articles (practitioners) you can buy a year's access to the entire Journal of Chinese Medicine article archive.
Forget the Information Age, we have entered … the Ozempic Era. Here in the UK more and more of my patients and friends who struggle with their weight have either started on – or want a Chinese medicine-informed opinion on – GLP-1 receptor agonist drugs (aka ‘fat jabs’ – the preposterously-named Ozempic, Wegovy, Mounjaro etc). As a dyed-in-the-wool Chinese medicine physician it irks me to admit it, but boy, do they work* (*after a fashion – see below).
| Author | Daniel Maxwell |
|---|---|
| JCM Issue | JCM142 |
* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.
